AVAC issued its annual report, Let's Step Up the Pace, which recomments five essential actions in 2013:

• End confusion about “combination prevention”.
• Narrow the gaps in the treatment cascade.
• Plan for the impact of new non-surgical male circumcision devices.
• Define and launch the “core package” of PrEP demonstration projects.
• Safeguard HIV prevention research funding.

Read the full report on AVAC's web site.

The U.S. Military HIV Research Program released its first newsletter, which provides updates on the latest in HIV prevention research.  Sign up to receive the newsletter or download  it from the MHRP's web site.

The Global HIV Vaccine Enterprise will convene partners from around the world to address two priority issues in HIV vaccine research and development: HIV prevention trials in infants, and vaccine-induced sero-positivity.  Click here to read the full announcement. 

Scientists from around the world will gather in Boston at AIDS Vaccine 2012 to present more than 400 new research studies updating global progress in the search for a safe and effective HIV vaccine.  The conference, hosted by the Global HI Vaccine Enterprise, Harvard Center for AIDS Research and the Ragon Institute, runs 09 - 12 September.  Read More.

Join us for an interactive session where we will review exciting developments that are opening new avenues in HIV vaccine science. The session features Margaret McCluskey of USAID, Mitchell Warren of AVAC, Nina Russell from the Gates Foundation, Bill Snow from the Enterprise and many others.  Visit, http://pag.aids2012.org/session.aspx?s=160 for more information.

The Enterprise launched Timely Topics in HIV Vaccines to analyze, address and respond to strategic issues in the field.  We are seeking proposals for hot topics that will help move the HIV vaccine endeavor forward.  For more information, visit http://www.vaccineenterprise.org/content/timely-topics-hiv-vaccines. 

Bloomberg ran a piece on the Pox-Protein Public Private Partnership (P5) and their plans to improve on the RV144 Thai HIV vaccine trial results. Check it out, http://www.bloomberg.com/news/2012-06-26/shark-oil-for-aids-takes-cue-fr....

AIDS Vaccine Research Subcommittee Meeting Report, May 2012

The NIH held its regular AIDS Vaccine Research Subcommittee (AVRS) meeting on May 15-16, 2012. The meeting focused on the latest progress and challenges in NHP research and followed up on a similar AVRS meeting held in May of 2010.  To read a full Enterprise report on the meeting, click here.

Keystone Symposia, February 2013

In its World AIDS Vaccine Day statement, the Public Health Agency of Canada noted that through the Canadian HIV Vaccine Intiative, five new research teams are dedicating their work to accelerating HIV vaccine R&D, which is helping to strengthen the links between Canadian and other researchers around the world.  

In an editorial published in the Mail & Guardian, Michel Sidibe, Chidi Nweneka and Margaret McGlynn wrote that despite the advances in the management of HIV, an effective vaccine to prevent HIV would save billions.  The full piece can be found here, http://mg.co.za/article/2012-05-18-vaccine-is-the-best-hope-against-aids.